Evidence map›Paper›PMID 24525859›Full record

ArticleRNA biology2014

The emerging roles of eRNAs in transcriptional regulatory networks.

Kambiz Mousavi, Hossein Zare, Miroslav Koulnis, Vittorio Sartorelli

Abstract read
In one paragraph

Article in RNA biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Chromatin remodeling effects on enhancer activity.Cellular and molecular life sciences : CMLS · 2016
    Review
  16. Review
  17. Article
  18. Article
  19. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kambiz MousaviModerna Therapeutics Inc.; Cambridge, MA USA.
Hossein ZareLaboratory of Muscle Stem Cells and Gene Regulation; National Institute of Arthritis, Musculoskeletal, and Skin Diseases; National Institutes of Health; Bethesda, MD USA.
Miroslav KoulnisLaboratory of Muscle Stem Cells and Gene Regulation; National Institute of Arthritis, Musculoskeletal, and Skin Diseases; National Institutes of Health; Bethesda, MD USA.
Vittorio SartorelliLaboratory of Muscle Stem Cells and Gene Regulation; National Institute of Arthritis, Musculoskeletal, and Skin Diseases; National Institutes of Health; Bethesda, MD USA.

Funding

Control of Myogenesis and Regulation of MyoD Post-Transcriptional ModificationsZIAAR041126 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SARTORELLI, VITTORIO · 2009 to 2025
$28.7M
6 · The paper itself

Abstract

Following reports by ENCyclopedia Of DNA Elements (ENCODE; GENCODE) Consortium and others, it is now fairly evident that the majority (70-80%) of the mammalian genome has the potential to be transcribed into non-protein-coding RNAs (ncRNAs). Critical to our understanding of genetic processes is the mechanism by which ncRNAs exert their roles. Accordingly, ncRNAs are shown to regulate the expression of protein-coding loci (i.e., genes) at the transcriptional as well as post-transcriptional stages. We recently reported on a widespread transcription at the DNA enhancer elements in myogenic cells. In our study, we found certain enhancer RNAs (eRNAs) regulate chromatin accessibility of the transcriptional machinery at loci encoding master regulators of myogenesis (i.e., MyoD/MyoG), thus suggesting their significance and site-specific impact in cellular programming. Here, we examine recent discoveries pertinent to the proposed role(s) of eRNAs in regulating gene expression. We will highlight consistencies, discuss confounding observations, and consider a lack of critical information in a way to prioritize future objectives.

Indexed as

Enhancer Elements, GeneticGene Regulatory NetworksTranscription, GeneticChromatinGenome, HumanGenomicsHumansModels, GeneticMuscle DevelopmentPromoter Regions, GeneticRNAChromatinRNAchromatinenhancerseRNAhistonesmRNA synthesistranscription

Identifiers

PMID24525859
PMCPMC3973729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.